During the past decade, Welch Cancer Center conducted 150 clinical trials. In the 10-year time frame, 150 clinical trials started and 195 clinical trials were completed, i.e. on average, 130% percent of trials that started reached the finish line to date. In the past 5 years, 60 clinical trials started and 78 clinical trials were completed. i.e. 130% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Welch Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 148 trials, followed by "SWOG Cancer Research Network" with 102 trials sponsored, "Alliance for Clinical Trials in Oncology" with 95 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 22 trials sponsored and "Eastern Cooperative Oncology Group" with 22 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Welch Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 258 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Cancer and Leukemia Group B" with 15 trials as a collaborator, "Eastern Cooperative Oncology Group" with 14 trials as a collaborator and "NCIC Clinical Trials Group" with 14 trials as a collaborator. Other collaborators include 58 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Welch Cancer Center" are "Breast Cancer" (34 trials), "Lung Cancer" (22 trials), "Lymphoma" (17 trials), "Leukemia" (14 trials) and "Prostate Cancer" (11 trials). Many other conditions were trialed in "Welch Cancer Center" in a lesser frequency.

Most popular intervention types in "Welch Cancer Center" are "Drug" (331 trials), "Other" (207 trials), "Biological" (159 trials), "Procedure" (81 trials) and "Radiation" (52 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (96 trials), "Quality-of-Life Assessment" (63 trials), "Paclitaxel" (37 trials), "Carboplatin" (35 trials) and "Questionnaire Administration" (34 trials). Other intervention names were less common.

The vast majority of trials in "Welch Cancer Center" are 323 trials for "All" genders, 68 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are NaN active trials in "Welch Cancer Center". undefined are not yet recruiting, 59 are recruiting, 123 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 180 completed trials in Welch Cancer Center, 6 suspended trials, and 34 terminated clinical trials to date.

Out of the total trials that were conducted in Welch Cancer Center, 18 "Phase 1" clinical trials were conducted, 206 "Phase 2" clinical trials and 182 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".